Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) FCF Margin (2020 - 2022)

Historic FCF Margin for Therapeutics (RAPT) over the last 3 years, with Q2 2022 value amounting to 1778.89%.

  • Therapeutics' FCF Margin fell 1701500.0% to 1778.89% in Q2 2022 from the same period last year, while for Mar 2023 it was 8493.23%, marking a year-over-year decrease of 65324900.0%. This contributed to the annual value of 4689.98% for FY2022, which is 30697100.0% down from last year.
  • Per Therapeutics' latest filing, its FCF Margin stood at 1778.89% for Q2 2022, which was down 1701500.0% from 2453.51% recorded in Q1 2022.
  • Therapeutics' FCF Margin's 5-year high stood at 503.29% during Q2 2020, with a 5-year trough of 2787.7% in Q4 2021.
  • Its 3-year average for FCF Margin is 1439.12%, with a median of 1248.38% in 2020.
  • Its FCF Margin has fluctuated over the past 5 years, first plummeted by -15941500bps in 2021, then plummeted by -1701500bps in 2022.
  • Quarter analysis of 3 years shows Therapeutics' FCF Margin stood at 1193.55% in 2020, then crashed by -134bps to 2787.7% in 2021, then skyrocketed by 36bps to 1778.89% in 2022.
  • Its last three reported values are 1778.89% in Q2 2022, 2453.51% for Q1 2022, and 2787.7% during Q4 2021.